Recruiting
Phase 3

Dose-Escalated Radiation

Sponsor:

NRG Oncology

Code:

NCT06958328

Conditions

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma

Stage II Pancreatic Cancer AJCC v8

Stage III Pancreatic Cancer AJCC v8

Stage IV Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy Procedure

Biospecimen Collection

Capecitabine

Computed Tomography

Dose-escalated Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-20. This information was provided to ClinicalTrials.gov by NRG Oncology on 2026-04-08.